Horizon Pharma plc to Present at the 35th Annual J.P. Morgan Healthcare Conference

DUBLIN, Ireland, Dec. 22, 2016 -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced that it plans to present at the 35^th Annual J.P. Morgan Healthcare Conference.  Timothy P. Walbert, chairman, president and chief executive officer, will present at 7:30 a.m. Pacific Time on January 10, 2017.

The presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com.  A replay of the webcast will be available following the event.

About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs.  Horizon Pharma markets 11 medicines through its orphan, rheumatology and primary care business units.  For more information, please visit www.horizonpharma.com.  Follow @HZNPplc on Twitter or view careers on our LinkedIn page.

Contacts:

Investors:
Tina Ventura
Senior Vice President, Investor Relations
[email protected] 

U.S. Media:
Geoff Curtis
Senior Vice President, Corporate Communications 
[email protected]

Ireland Media:
Ray Gordon
Gordon MRM 	
[email protected]